Dr. Arnot joins an elite board assembled to aid the advancement of innovative technologies being developed to address brain injury and other life saving medical conditions

阿诺特博士加入了一个精英董事会，以帮助发展的创新技术，以解决脑损伤和其他挽救生命的医疗条件

IRVINE, CA, May 11, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to welcome best selling author and award winning journalist Dr. Bob Arnot, M.D., to its Scientific Advisory Board (SAB).

加州欧文市，2021年5月11日(GLOBE NEWSWIRE)——奥德赛集团国际有限公司(以下简称“公司”或“奥德赛”)是一家专注于开发独特、拯救生命的医疗产品的技术和资产收购公司，欢迎畅销书作家和获奖记者Dr. Bob Arnot, m.d.，科学顾问委员会(SAB)。

Dr. Arnot is the former Chief Medical Correspondent at Dateline NBC, The Today Show, NBC Nightly News, CBS News, CBS Evening News, 48 Hours, and CBS This Morning. He was also Chief Foreign Correspondent at NBC and MSNBC, Dr. Bob has won or been nominated for several Emmy Awards. He has also incredibly authored 15 best selling books on health, nutrition and exercise, including the New York Times best seller, The Aztec Diet. Arnot’s latest book, Flip the Youth Switch, was released in 2020.

Arnot博士是前首席医疗记者在日期NBC，今日秀，NBC晚间新闻，CBS新闻，CBS晚间新闻，48小时，CBS今晨。他也是NBC和MSNBC的首席驻外记者，鲍勃博士获得或被提名艾美奖。令人难以置信的是，他还写了15本关于健康、营养和锻炼的畅销书，包括《纽约时报》的畅销书《阿兹特克饮食》。阿诺特的新书《拨开青春的开关》(Flip the Youth Switch)于2020年出版。

Dr. Arnot is the current Dean of Advanced Technology and International Education at the New York Film Academy. He previously served on the board for Pine Manor College and Harvard affiliated Joslin Diabetes centers Board of Incorporators, and was the National Medical Director of National Emergency Services. Dr. Arnot is current engaged in executing analytical chemistry and clinical trials for major consumer packaged goods companies and the pharmaceutical industry. He’s been active in COVID working on COVID education with an urgent response group at a major medical center, local states and a major technology company as well as appearing on national and international television platforms through Europe, Africa and the far East

Arnot博士是纽约电影学院先进技术和国际教育的现任院长。他曾任职于Pine Manor College和Harvard附属Joslin糖尿病中心董事会，并担任国家紧急服务的国家医疗主任。他目前从事主要消费品包装公司和制药行业的分析化学和临床试验。他在一家大型医疗中心、地方各州和一家大型科技公司的应急小组中积极参与新冠肺炎疫情教育工作，并出现在欧洲、非洲和远东的国家和国际电视平台上

A lifetime humanitarian, Dr. Bob is the Founder and Chairman of Lifeline Iraq, the President of Heal for Peace, a Cofounder of the American Working Group on Greater Syria, and the Chief Medical Officer of the Humanitarian Niveneh Organization. He has served on Boards for the UN High Commission for Refugees, Artists for Peace and Justice, the US Committee for Refugee, Save the Children, the Lindberg Foundation, and Heal for Peace, HNRO.

鲍勃博士终身从事人道主义工作，是伊拉克生命线组织、治愈和平组织总统的创始人和主席，美国大叙利亚问题工作组的共同创始人，人道主义尼尼赫组织的首席医务官。他曾任职于联合国难民事务高级委员会、和平与正义艺术家委员会、美国难民委员会、拯救儿童基金会、林德伯格基金会和和平治愈委员会(HNRO)。

“Dr. Bob’s deep experience and resume precedes him and we are excited to have him join the Odyssey team,” commented Michael Redmond, CEO of Odyssey, “He has been involved with clinical trials and has had commercial success with several products, he brings a wealth of wisdom to the scientific arena. Dr. Arnot has personal knowledge of concussion and is motivated to help develop a treatment. Having him join our Scientific Advisory Board will help us guide the development and clinical trials of PRV-002, helping us improve outcomes for concussion patients.

”博士。奥德赛的首席执行官Michael Redmond说:“他参与了一些临床试验，并在一些产品上取得了商业成功，他为科学领域带来了丰富的智慧。阿诺特医生对脑震荡有个人的了解，并积极帮助开发治疗方法。让他加入我们的科学顾问委员会将帮助我们指导PRV-002的开发和临床试验，帮助我们改善脑震荡患者的预后。

Dr. Arnot joins a stellar Scientific Advisory Board that includes James P. Kelly, MA, MD, FAAN, FANA, and Dallas C. Hack, MD, MPH, FACMPH, COL, US Army. The SAB will guide and advise the Company as it advances its proprietary platforms developing innovative technologies that address unmet medical needs. The Company is in the pre-clinical phase of development of a drug compound (PRV-002) and is currently preparing for its first human clinical trial.

Arnot博士加入了一流的科学顾问委员会，包括James P. Kelly, MA, MD, FAAN, FANA和Dallas C. Hack, MD, MPH, FACMPH, COL, US Army。SAB将指导和建议公司推进其专有平台开发创新技术，以解决未满足的医疗需求。该公司正处于一种药物化合物(PRV-002)的临床前开发阶段，目前正准备进行首次人体临床试验。

“Concussion is one of the conditions I have witnessed globally whose negative effects are grossly underestimated,” said Dr. Arnot, “That’s why I am thrilled to join Odyssey’s Scientific Advisory Board and to help push the development of the much needed technologies in the Odyssey pipeline.”

“脑震荡是我在全球目睹的负面影响被严重低估的情况之一，”阿诺特博士说，“这就是为什么我很高兴加入奥德赛的科学顾问委员会，并帮助推动奥德赛管道急需的技术的发展。”

About Odyssey Group International, Inc.

关于奥德赛国际集团

Odyssey Group International, Inc. (OTCQB:ODYY) is a technology and asset acquisition company with a focus in the area of life saving medical solutions. Odyssey's corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, have a substantial market opportunity and provide solid returns to its valued shareholders and partners.

奥德赛集团国际有限公司(OTCQB:ODYY)是一家专注于救生医疗解决方案领域的技术和资产收购公司。奥德赛的企业使命是创造、收购和积累独特的资产、知识产权和卓越的技术，以提供有意义的医疗解决方案。公司专注于建立和收购具有确定的技术优势，提供卓越的临床效用，有大量的市场机会，并为其有价值的股东和合作伙伴提供坚实的回报的领域的资产。